1. European Medicines Agency (2008) The rules governing medicinal products in the European Union, volume 9A. Available at: http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-9/pdf/vol9a_09-2008.pdf . Accessed 2 Aug 2011
2. Waring WS, McGettigan P (2011) Clinical toxicology and drug regulation: a United Kingdom perspective. Clin Toxicol (Phila) 49(6):452–456
3. Ridley DB, Kramer JM, Tilson HH, Grabowski HG, Schulman KA (2006) Spending on postapproval drug safety. Health Aff (Millwood) 25(2):429–436
4. Counsel for International Organizations of Medical Sciences (CIOMS) (1992). International reporting of periodic drug-safety update summaries. Final Report of CIOMS working group II. CIOMS, Geneva
5. International Conference on Harmonisation (ICH) (2010) Final concept paper periodic safety update reports for marketed drugs E2C(R2) and gap and potential improvement analysis of ICH E2C, E2E and E2F. ICH, Geneva